Sopharma Trading is appointing a general meeting of shareholders June 8, 2007 in order to vote the company’s listing as a public company in compliance with the Law on public offerings of securities, the State Gazette announced.

Shareholders will entrust the Board of Directors to take all necessary procedures for the approval and for the filing with the Financial Supervision Commission of the prospectus for a secondary public offering of shares as well as for the registration of the emission for trade on the regulated market with the Financial Supervision Commission and for the share’s admission for trade on the BSE-Sofia.

Shareholders are also to vote the proposal to change the type of the company’s shares according to which all shares will become dematerialized.

A capital increase is also to be voted from the current 20 mln leva to 30 mln leva through the issuance of 10 mln common, dematerialized, non-voting shares with a nominal value of 1 lev.

Each shareholder will be entitled to acquire a number of the new shares in proportion to their participation in the capital prior to its increase – each 2 shares before the increase entitle to the subscription of one new share.

Another proposal is to use the 2006 profit (after setting aside the regulated amount to the Reserves Fund) for covering losses from prior periods.

Main shareholders in the company are Telso Ad controlling 45.33% of the capital, Bulgarian-American Investment Fund holding 33.4% and Tatyana Draculova holding 11 %.